Hypoglycemic adverse reactions to insulin and sulfonylureas.
Clearly, the insulins and oral sulfonylureas, while providing life-sustaining therapeutic effects, frequently cause serious, severe, and sometimes permanent and fatal adverse outcomes. A thorough understanding of their proper indications, requisite monitoring, patient education, and avoidance of interactive risks provide care givers with a clinical challenge each time these agents are used by their patients.